X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE SHASUN PHARMA TTK HEALTHCARE/
SHASUN PHARMA
 
P/E (TTM) x 17.5 123.9 14.1% View Chart
P/BV x 4.5 8.5 52.6% View Chart
Dividend Yield % 0.6 0.2 277.6%  

Financials

 TTK HEALTHCARE   SHASUN PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
SHASUN PHARMA
Mar-14
TTK HEALTHCARE/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs66394 704.2%   
Low Rs39946 875.0%   
Sales per share (Unadj.) Rs535.6214.2 250.1%  
Earnings per share (Unadj.) Rs15.95.3 298.8%  
Cash flow per share (Unadj.) Rs20.015.8 126.6%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.81.4 52.6%  
Book value per share (Unadj.) Rs137.653.3 258.0%  
Shares outstanding (eoy) m7.7756.62 13.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.3 303.9%   
Avg P/E ratio x33.313.1 254.3%  
P/CF ratio (eoy) x26.54.4 600.3%  
Price / Book Value ratio x3.91.3 294.6%  
Dividend payout %25.118.7 133.9%   
Avg Mkt Cap Rs m4,1273,958 104.3%   
No. of employees `0001.7NA-   
Total wages/salary Rs m6072,164 28.0%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,16212,127 34.3%  
Other income Rs m61229 26.7%   
Total revenues Rs m4,22312,356 34.2%   
Gross profit Rs m1971,009 19.5%  
Depreciation Rs m32594 5.3%   
Interest Rs m30415 7.2%   
Profit before tax Rs m197230 85.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-73 -100.1%   
Profit after tax Rs m124302 41.0%  
Gross profit margin %4.78.3 56.9%  
Effective tax rate %37.0-31.7 -116.9%   
Net profit margin %3.02.5 119.5%  
BALANCE SHEET DATA
Current assets Rs m1,6296,884 23.7%   
Current liabilities Rs m1,0588,456 12.5%   
Net working cap to sales %13.7-13.0 -105.8%  
Current ratio x1.50.8 189.1%  
Inventory Days Days3062 48.3%  
Debtors Days Days34108 31.2%  
Net fixed assets Rs m5564,970 11.2%   
Share capital Rs m78113 68.6%   
"Free" reserves Rs m8782,875 30.6%   
Net worth Rs m1,0693,020 35.4%   
Long term debt Rs m1591,817 8.7%   
Total assets Rs m2,39913,347 18.0%  
Interest coverage x7.61.6 487.9%   
Debt to equity ratio x0.10.6 24.7%  
Sales to assets ratio x1.70.9 190.9%   
Return on assets %6.45.4 119.3%  
Return on equity %11.610.0 115.8%  
Return on capital %18.513.3 138.5%  
Exports to sales %0.846.4 1.7%   
Imports to sales %1.414.2 9.8%   
Exports (fob) Rs m335,622 0.6%   
Imports (cif) Rs m581,728 3.4%   
Fx inflow Rs m335,843 0.6%   
Fx outflow Rs m632,173 2.9%   
Net fx Rs m-303,669 -0.8%   
CASH FLOW
From Operations Rs m127398 31.8%  
From Investments Rs m-146-1,635 8.9%  
From Financial Activity Rs m221,309 1.7%  
Net Cashflow Rs m371 3.5%  

Share Holding

Indian Promoters % 65.4 39.2 166.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 3.6 102.8%  
FIIs % 5.2 17.6 29.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 39.6 65.2%  
Shareholders   12,723 20,750 61.3%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   STERLING BIOTECH  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 146 Points Lower; IT and Power Stocks Drag(Closing)

Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.Sectoral indices ended on a mixed note with realty stocks.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 19, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS